Applications — HPLCmart

Classification

Compound

Mode

More criteria

Column vendor

Length, mm

Int. diameter, mm

Particle size, μm

Pore size, Å

Found 4,302

Already have a column?

Column name

Showing 4,302 applications

Sort by:

ID	Classification	Compounds	Linked columns
PDF 2019	Drugs Pharmaceuticals	15 compounds a-Hydroxyalprazolam Alprazolam Alprazolam-D5 Clonazepam Clonazepam-D4 Diazepam Diazepam-D5 Lorazepam Lorazepam-D4 Nordiazepam Nordiazepam D5 Oxazepam Oxazepam D5 Temazepam Temazepam D5	Phenomenex Kinetex C18 50 × 2.1 mm · 2.6 µm
PDF 2018	Drugs Pharmaceuticals	4 compounds Chlorpheniramine Diphenhydramine Maleic acid Triprolidine	Phenomenex Synergi Hydro-RP 150 × 4.6 mm · 4.0 µm
PDF 2017	Drugs Pharmaceuticals	2 compounds Acetaminophen Codeine	Phenomenex Synergi Hydro-RP 150 × 4.6 mm · 4.0 µm
PDF 2016	Drugs Pharmaceuticals	4 compounds Methylparaben Phenylephrine Phenylpropanolamine Pseudoepherine	Phenomenex Synergi Hydro-RP 150 × 4.6 mm · 4.0 µm
PDF 2015	Pharmaceuticals Vitamins	5 compounds p-Aminobenzoic acid Pantothenic acid Pyridoxine Riboflavin Thiamine	Phenomenex Synergi Polar-RP 150 × 4.6 mm · 4.0 µm
PDF 2014	Drugs Pharmaceuticals	8 compounds Chlordiazepoxide Clonazepam Desmethyldiazepam Diazepam Impurity Lorazepam Oxazepam Temazepam	Phenomenex Synergi Hydro-RP 150 × 4.6 mm · 4.0 µm
PDF 2013	Drugs Pharmaceuticals	3 compounds Betamethasone Betamethasone Valerate Butylparaben	Phenomenex Synergi Max-RP 150 × 4.6 mm · 4.0 µm
PDF 2012	Drugs Pharmaceuticals	2 compounds Lovastatin Simvastatin	Phenomenex Kinetex C8 50 × 4.6 mm · 2.6 µm
PDF 2011	Drugs Pharmaceuticals	5 compounds Amobarbital Butabarbital Butalbital Phenobarbital Secobarbital	Phenomenex Synergi Max-RP 150 × 4.6 mm · 4.0 µm
PDF 2010	Drugs Pharmaceuticals	8 compounds Chlodiazepoxide Clonazepam Deazepam Desmethyldiazepam Impurity Lorazepam Oxazepam Temazepam	Phenomenex Synergi Polar-RP 150 × 4.6 mm · 4.0 µm
PDF 2009	Drugs Pharmaceuticals	3 compounds Ibuprofen Ibuprofen related compound C Valerophenone	Phenomenex Kinetex XB-C18 75 × 4.6 mm · 2.6 µm
PDF 2008	Drugs Pharmaceuticals	1 compounds Propranolol	Phenomenex Synergi Fusion-RP 150 × 4.6 mm · 4.0 µm
PDF 2007	Drugs Pharmaceuticals	3 compounds Ibuprofen Ibuprofen related compound C Valerophenone	Phenomenex Kinetex XB-C18 75 × 4.6 mm · 2.6 µm
PDF 2006	Pharmaceuticals Sulfonamides	5 compounds Sulfamerazine Sulfamethoxazole Sulfanilamide Sulfaquinoxaline Sulfathiazole	Phenomenex Synergi Fusion-RP 150 × 4.6 mm · 4.0 µm
PDF 2005	Pharmaceuticals Steroids	5 compounds 17-Hydroxyprogesterone Cortisone Cortisone-21-Acetate Deoxycorticosterone Hydrocortisone	Phenomenex Kinetex XB-C18 75 × 4.6 mm · 2.6 µm
PDF 2004	Drugs Pharmaceuticals	3 compounds Phenylephrine Phenylpropanolamine Pseudoephedrine	Phenomenex Synergi Fusion-RP 150 × 4.6 mm · 4.0 µm
PDF 2003	Drugs Pharmaceuticals	8 compounds Chlordiazepoxide Clonazepam Desmethyldiazepam Diazepam Impurity Lorazepam Oxazepam Temazepam	Phenomenex Synergi Max-RP 150 × 4.6 mm · 4.0 µm
PDF 2002	Drugs Pharmaceuticals	4 compounds Chlorpheniramine Diphenhydramine Maleic acid Triprolidine	Phenomenex Synergi Fusion-RP 150 × 4.6 mm · 4.0 µm
PDF 2001	Pharmaceuticals Steroids	5 compounds 17-Hydroxyprogesterone Cortisone Cortisone-21-Acetate Deoxycorticosterone Hydrocortisone	Phenomenex Kinetex XB-C18 150 × 4.6 mm · 2.6 µm
PDF 2000	Antibiotics Pharmaceuticals	3 compounds chloramphenicol Chloramphenicol-d5 Impurity	Phenomenex Kinetex C18 50 × 2.1 mm · 2.6 µm
PDF 1999	Pharmaceuticals Vitamins	3 compounds 25-hydroxyvitamin D2 (25-OH D2) 25-hydroxyvitamin D3 (25-OH D3) 25-hydroxyvitamin D3-d6 (25-OH D3-d6)	Phenomenex Kinetex C18 50 × 4.6 mm · 2.6 µm
PDF 1998	Pharmaceuticals Vitamins	3 compounds 25-hydroxyvitamin D2 (25-OH D2) 25-hydroxyvitamin D3 (25-OH D3) 25-hydroxyvitamin D3-d6 (25-OH D3-d6)	Phenomenex Kinetex C18 50 × 4.6 mm · 2.6 µm
PDF 1997	Drugs Pharmaceuticals	12 compounds Acebutolol Acetaminophen Amitriptyline Dextromethorphan Diflunisal Diphenhydramine Fluoxetine Folic acid Indomethacin Procainamide Propafenone Sulfathiazole	Phenomenex Kinetex C18 100 × 4.6 mm · 2.6 µm
PDF 1996	Opiates Pharmaceuticals	6 compounds 6-MAM D3-6-MAM d5-PCP d9-Methadone Methadone PCP	Phenomenex Kinetex C18 50 × 2.1 mm · 2.6 µm
PDF 1995	Biochemistry Organic acids	5 compounds Citric Acid Lactic Acid Maleic acid Malic Acid Tartaric acid	Phenomenex Synergi Fusion-RP 150 × 4.6 mm · 4.0 µm
PDF 1994	Opiates Pharmaceuticals	6 compounds 6-MAM D3-6-MAM d5-PCP d9-Methadone Methadone PCP	Phenomenex Kinetex C18 50 × 2.1 mm · 2.6 µm
PDF 1993	Drugs Pharmaceuticals	2 compounds Methoxyverapamil Verapamil	Phenomenex Synergi Fusion-RP 150 × 4.6 mm · 4.0 µm
PDF 1992	Drugs Pharmaceuticals	2 compounds Fenofibrate Gemfibrozil	Phenomenex Synergi Fusion-RP 150 × 4.6 mm · 4.0 µm
PDF 1991	Drugs Pharmaceuticals	2 compounds Diflunisal Flurbiprofen	Phenomenex Synergi Fusion-RP 150 × 4.6 mm · 4.0 µm
PDF 1990	Drugs Pharmaceuticals	3 compounds Lidocaine Noscapine Scopolamine	Phenomenex Synergi Fusion-RP 150 × 4.6 mm · 4.0 µm
PDF 1989	Drugs Pharmaceuticals	2 compounds Butyrophenone Naproxen	Phenomenex Synergi Fusion-RP 150 × 4.6 mm · 4.0 µm
PDF 1988	Drugs Pharmaceuticals	4 compounds Chlorpheniramine Diphenhydramine Maleic acid Triprolidine	Phenomenex Synergi Fusion-RP 150 × 4.6 mm · 4.0 µm
PDF 1987	Pharmaceuticals Steroids	3 compounds Estradiol Estrone Ethyl Parabene	Phenomenex Synergi Fusion-RP 150 × 4.6 mm · 4.0 µm
PDF 1986	Pharmaceuticals Steroids	2 compounds Cortisone-21-Acetate Hydrocortisone	Phenomenex Synergi Fusion-RP 150 × 4.6 mm · 4.0 µm
PDF 1985	Pharmaceuticals Steroids	1 compounds Hydrocortisone	Phenomenex Synergi Fusion-RP 150 × 4.6 mm · 4.0 µm
PDF 1984	Drugs Pharmaceuticals	2 compounds Benzoic Acid Guaiacol glyceryl ether	Phenomenex Synergi Fusion-RP 150 × 4.6 mm · 4.0 µm
PDF 1983	Drugs Pharmaceuticals	8 compounds 3-methyl 4-benzoic acid 3-methyl salicylaldehyde Benzyl alcohol Phenol Pyridine Quinidine Sulfathiazole Triprolidine	Phenomenex Synergi Polar-RP 150 × 4.6 mm · 4.0 µm
PDF 1982	Drugs Pharmaceuticals	3 compounds Diphenhydramine Doxylamine Scopalamine	Phenomenex Synergi Max-RP 150 × 4.6 mm · 4.0 µm
PDF 1981	Drugs Pharmaceuticals	3 compounds Diphenhydramine Doxylamine Scopalamine	Phenomenex Synergi Max-RP 150 × 4.6 mm · 4.0 µm
PDF 1980	Drugs Pharmaceuticals	2 compounds Naphazoline Pheniramine	Phenomenex Synergi Max-RP 150 × 4.6 mm · 4.0 µm
PDF 1979	Drugs Pharmaceuticals	1 compounds Chlorpheniramine	Phenomenex Synergi Max-RP 150 × 4.6 mm · 4.0 µm
PDF 1978	Drugs Pharmaceuticals	5 compounds Amitriptyline Clomipramine Desipramine Doxepine Imipramine	Phenomenex Synergi Max-RP 150 × 4.6 mm · 4.0 µm
PDF 1977	Pharmaceuticals Steroids	3 compounds Estradiol Estrone Ethyl Parabene	Phenomenex Synergi Max-RP 150 × 4.6 mm · 4.0 µm
PDF 1976	Pharmaceuticals Sulfonamides	4 compounds Sulfamethoxazole Sulfanilamide Sulfaquinoxaline Sulfathiazole	Phenomenex Synergi Max-RP 150 × 4.6 mm · 4.0 µm
PDF 1975	Drugs Pharmaceuticals	4 compounds Caffeine Indoprofen Ketoprofen Naproxen	Phenomenex Synergi Polar-RP 250 × 4.6 mm · 4.0 µm
PDF 1974	Opiates Pharmaceuticals	3 compounds Morphine Morphine-3-b-glucuronide Normorphine	Phenomenex Synergi Polar-RP 100 × 2.0 mm · 4.0 µm
PDF 1973	Drugs Pharmaceuticals	2 compounds Acyclovir Ganciclovir	Phenomenex Synergi Fusion-RP 100 × 2.0 mm · 4.0 µm
PDF 1972	Drugs Pharmaceuticals	7 compounds Bromopheniramine Chlorpheniramine Chlorphenoxamine Diphenhydramine Doxylamine Loratadine Malic Acid	Phenomenex Synergi Polar-RP 150 × 4.6 mm · 4.0 µm
PDF 1971	Pharmaceuticals Sulfonamides	3 compounds Sulfamerazine Sulfamethoxazole Sulfathiazole	Phenomenex Synergi Polar-RP 150 × 4.6 mm · 4.0 µm
PDF 1970	Drugs Pharmaceuticals	2 compounds Acyclovir Ganciclovir	Phenomenex Synergi Fusion-RP 150 × 4.6 mm · 4.0 µm

Showing 2,351–2,400 of 4,302

← Prev4041424344454647484950515253545556Next page →